...
首页> 外文期刊>Annals of Saudi medicine. >Effect of Thyroid Hormone Replacement Therapy on Ovarian Volume and Androgen Hormones in Patients with Untreated Primary Hypothyroidism
【24h】

Effect of Thyroid Hormone Replacement Therapy on Ovarian Volume and Androgen Hormones in Patients with Untreated Primary Hypothyroidism

机译:甲状腺激素替代疗法对未经治疗的原发性甲状腺功能减退症患者卵巢容量和雄激素的影响

获取原文
           

摘要

BACKGROUND AND OBJECTIVES: Primary hypothyroidism may be associated with ovarian enlargement and/ or cyst formation. We evaluated the effect of thyroid hormone replacement therapy on hormonal changes, ovarian volume and sonographic appearance. DESIGN AND SETTING: Open, prospective study of women admitted to university gynecology clinic. PATIENTS AND METHODS: The study included 26 patients with untreated hypothyroidism who had polycystic (n=10) or normal-appearing (n=16) ovaries and 20 euthyroidic controls. Basal serum total testosterone, free testosterone, androstenedione, dehydroepiandosterone-sulfate, prolactin, estradiol, luteinizing hormone, follicle-stimulating hormone, free T3, free T4 and thyroid-stimulating horone, together with ovarian volumes, were determined and repeated after euthyroidism was achieved. RESULTS: Ovarian volumes of patients with hypothyroidism were significantly greater compared with controls, and their magnitudes diminished significantly during thyroid hormone replacement therapy. Hypothyroidic patients with polycystic ovaries had significantly higher serum free testosterone and dehydroepiandosterone- sulfate, but lower androstenodione levels compared with those who had normal-appearing ovaries. Serum total testosterone concentrations were significantly higher in hypothyroidic patients without polycystic ovaries, and thyroid hormone replacement therapy achieved a significant reduction in total as well as free testosterone. CONCLUSION: Severe longstanding hypothyroidism leads to increased ovarian volume and/or cyst formation. A decrease in ovarian volume, resolution of ovarian cysts and reversal of the polycystic ovary syndrome-like appearance, together with improvement in serum hormone levels, occurred after euthyroidism was achieved. Ann Saudi Med 2011; 31(2): 145-151 PMID: 21403408 DOI: 10.4103/0256-4947.77500.
机译:背景与目的:原发性甲状腺功能减退可能与卵巢肿大和/或囊肿形成有关。我们评估了甲状腺激素替代疗法对荷尔蒙变化,卵巢体积和超声检查外观的影响。设计与地点:对进入大学妇科诊所的女性进行的开放性,前瞻性研究。患者与方法:该研究包括26例未经治疗的甲状腺功能减退症患者,这些患者患有多囊卵巢(n = 10)或正常出现(n = 16)卵巢和20例甲状腺功能正常的对照。确定基础血清总睾丸激素,游离睾丸激素,雄烯二酮,硫酸脱氢表雄酮,催乳素,雌二醇,促黄体生成素,促卵泡激素,游离T3,游离T4和促甲状腺激素以及卵巢体积,并在达到甲状腺功能正常后重复。结果:与对照组相比,甲状腺功能减退患者的卵巢容量明显更大,并且在甲状腺激素替代治疗期间其数量明显减少。甲状腺功能减退的多囊卵巢患者的血清游离睾丸激素和硫酸脱氢表雄酮硫酸盐水平明显高于卵巢正常的患者。没有多囊卵巢的甲状腺功能减退患者的血清总睾丸激素浓度显着较高,甲状腺激素替代疗法的总睾丸激素和游离睾丸激素均显着降低。结论:严重的长期甲状腺功能减退症导致卵巢体积增加和/或囊肿形成。甲状腺功能亢进症发生后,卵巢体积减少,卵巢囊肿消退,多囊卵巢综合征样外观逆转以及血清激素水平提高。 Ann Saudi Med 2011; 31(2):145-151 PMID:21403408 DOI:10.4103 / 0256-4947.77500。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号